Background: New preventive strategies recommended after acute coronary syndrome (ACS) such as the prescription PCSK9 inhibitors drugs are expensive, and may be limited to people with high socio-economic status. However, in countries with universal health insurance coverage like in Switzerland, income shouldn't influence optimal control of cardiovascular risk factors (CVRF).
Purpose: We aim to assess the association between income and control of CVRF one-year after ACS in Switzerland.
Methods: Between January 2013 and August 2014, we studied 244 patients from a prospective cohort of patients hospitalized with ACS in one academic center in Switzerland. We assessed household income at baseline and at one-year follow-up with a validated self-reported questionnaire, and stratified patients in 3 income categories (1) high defined as more than 9000 CHF per month, medium, defined...